Search
for
Sort by
Research 211–240 of 1000+
- Cosmeceutical Treatments for Androgenetic Alopecia
- The biology of hair diversity
- Androgenetic alopecia: pathogenesis and potential for therapy
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Pathogenesis of androgenetic alopecia
- Андроген-опосередковані й андрогенонезалежні причини алопеції та акне в жінок. Огляд літератури
- ANDROGENIC ALOPECIA: PATHOGENETIC MECHANISMS AND THERAPEUTIC APPROACHES
- Disorders linked to insufficient androgen action in male children
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”
- Treatment of female pattern hair loss with oral antiandrogens
- Role of insulin resistance and diet in acne
- Spermine Lipid Assembled Nanoparticles for siRNA Delivery and Androgenetic Alopecia Therapy
- Medical Management Options for Hair Loss
- Progressive expression of PPARGC1α is associated with hair miniaturization in androgenetic alopecia
- Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency epidemiology, etiopathogenesis, clinical presentation, treatment – a systematic review
- Disorders linked to insufficient androgen action in male children
- Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease
- 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production
- Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
- Anti-androgen hormonal therapy for cancer and other diseases
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Androgen Receptor Ligands: Agonists and Antagonists
- Mechanisms that regulate androgen receptor transcriptional activity
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia
- Novel DualSoftDrug Strategy Enables Developmentof Topical Androgen Receptor Antagonists with Enhanced Efficacy andOptimized Safety for Androgenetic Alopecia